SCHEMBL5658364

SCHEMBL5658364

COc1ccc(N2CCN(CCCN(C(=O)O)c3ccccc3OC)CC2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 4/20 0.58
DRD2 P14416 2/20 0.58
HTR1A P08908 3/20 0.55
KDM4E B2RXH2 1/20 0.54
ALDH1A1 P00352 1/20 0.54
HTR2C P28335 2/20 0.52
HTR7 P34969 2/20 0.52
HSD17B10 Q99714 1/20 0.51
KMT2A Q03164 3/20 0.50
DRD4 P21917 2/20 0.50
MEN1 O00255 2/20 0.50
DRD3 P35462 1/20 0.50
ADRB1 P08588 1/20 0.50
HTR2B P41595 1/20 0.50
SIGMAR1 Q99720 1/20 0.50
SLC6A2 P23975 1/20 0.49
SLC6A4 P31645 1/20 0.49
GFER P55789 1/20 0.49
OPRM1 P35372 1/20 0.49
POLB P06746 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5657422 0.94 HTR1A (0.57) HTR2ADRD2HTR1AKDM4EALDH1A1
SCHEMBL5657861 0.94 OPRM1 (0.55) HTR2ADRD2HTR1AKDM4EALDH1A1
SCHEMBL5657065 0.92 ALDH1A1 (0.51) HTR2ADRD2HTR1AALDH1A1HTR2C
SCHEMBL5657619 0.92 HTR7 (0.51) HTR2ADRD2HTR7KMT2ADRD4
SCHEMBL5655983 0.91 MAPT (0.53) HTR2ADRD2HTR1AHTR7DRD4
SCHEMBL5658289 0.90 HTR1A (0.58) HTR2ADRD2HTR1ADRD4DRD3
SCHEMBL5656281 0.90 OPRM1 (0.52) DRD2HTR1ADRD4SLC6A4GFER
SCHEMBL5655859 0.87 GFER (0.55) HTR2AHTR1AHTR7KMT2ADRD4
SCHEMBL5655837 0.86 DRD2 (0.63) HTR2ADRD2HTR1AKDM4EALDH1A1
SCHEMBL5656076 0.86 HTR1A (0.53) HTR2ADRD2HTR1AKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7238693-B2 Aryl carbamate derivatives, preparation and use thereof CEREP (FR) 2007-07-03 US disclosed
US-20040058933-A1 Aryl carbamate derivatives, preperation and use thereof CEREP (FR) 2004-03-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040058933-A1 Aryl carbamate derivatives, preperation and use thereof HTR4, HTR5A, HTR3C HTR2A 14/4885DRD2 73/4885HTR1A 8/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.